Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 14.07%994.4M | 21.25%1.03B | 143.58%1.29B | 59.98%816.63M | -7.81%871.77M | 0.48%849.64M | -42.31%529.42M | -52.77%510.47M | -10.93%945.62M | -50.54%845.61M |
Notes receivable and accounts receivable | -62.90%48.02M | -54.39%51.89M | -32.94%95.58M | -25.46%97M | -18.54%129.45M | -28.83%113.76M | -55.89%142.54M | -55.14%130.14M | -54.24%158.92M | -45.20%159.85M |
-Accounts receivable | -62.90%48.02M | -54.39%51.89M | -32.94%95.58M | -25.46%97M | -18.54%129.45M | -28.83%113.76M | -55.89%142.54M | -55.14%130.14M | -54.24%158.92M | -45.20%159.85M |
Other receivables (including interest and dividends) | -11.20%72.65M | -9.78%74.27M | -33.83%65.51M | -35.41%74.18M | -65.71%81.82M | -46.70%82.32M | -36.51%99M | -18.62%114.85M | 67.81%238.6M | 9.82%154.45M |
-Other receivable | ---- | ---- | ---- | -35.41%74.18M | ---- | -46.70%82.32M | ---- | -18.62%114.85M | ---- | 9.82%154.45M |
Advance payment | 27.16%107.1M | -46.88%82.9M | -24.54%117.95M | -3.09%107.12M | -43.71%84.22M | -54.03%156.04M | -59.82%156.3M | -71.18%110.54M | -61.48%149.62M | -6.23%339.42M |
Inventories | -39.57%253.53M | -29.77%325.17M | 68.33%291.48M | 27.86%312.72M | 22.28%419.55M | 48.55%462.98M | -67.98%173.16M | -68.61%244.59M | -72.01%343.12M | -80.21%311.67M |
Receivable financing | 2,282.04%1.43M | 1,174.48%385.44K | 172.66%761.63K | 1,846.80%584.04K | -44.22%60K | -98.36%30.24K | 35.62%279.33K | --30K | -93.23%107.56K | 360.16%1.84M |
Other current assets | 8.85%421.12M | -0.64%405.32M | -10.12%374.55M | -14.30%370.1M | -17.54%386.88M | -48.89%407.94M | -37.26%416.72M | -38.76%431.87M | -56.85%469.19M | -12.73%798.14M |
Total current assets | -3.83%1.9B | -4.95%1.97B | 47.32%2.24B | 15.29%1.78B | -14.38%1.97B | -20.62%2.07B | -49.27%1.52B | -54.37%1.54B | -45.82%2.31B | -47.72%2.61B |
Non Current assets | ||||||||||
Debt investment | 12.90%19.29M | -24.03%13.3M | 587.62%13.3M | 276.54%13.5M | 365.41%17.09M | -69.82%17.51M | -98.43%1.93M | -98.59%3.59M | -96.89%3.67M | -79.74%58.01M |
Other equity investment | -59.65%18.61M | -64.80%18.38M | -55.06%26.25M | -51.34%28.62M | -16.91%46.12M | -5.23%52.23M | -33.24%58.41M | -36.49%58.82M | -25.02%55.5M | -35.52%55.11M |
Investment real estate | -4.01%13.71B | -4.01%13.71B | -3.66%14.22B | -3.48%14.28B | -3.86%14.28B | -4.67%14.28B | -2.08%14.76B | -1.83%14.8B | 1.63%14.85B | 38.53%14.98B |
Long-term equity investment | -50.39%2.83M | -3.65%5.57M | -8.06%5.59M | -10.75%5.59M | 32.33%5.71M | 25.57%5.78M | -66.36%6.08M | -67.77%6.27M | -78.80%4.32M | -78.65%4.6M |
Fixed assets | ---- | ---- | ---- | -9.47%2.45B | ---- | -14.21%2.54B | ---- | -5.68%2.71B | ---- | 6.06%2.96B |
Constru in process | ---- | ---- | ---- | 19.28%1.31B | ---- | 35.85%1.31B | ---- | -0.47%1.1B | ---- | -75.35%962.78M |
Intangible assets | -17.29%1.27B | -17.25%1.28B | -3.62%1.53B | -3.89%1.55B | -3.28%1.54B | -7.04%1.55B | -6.76%1.59B | -6.38%1.61B | -7.11%1.59B | -36.99%1.67B |
Development expenditure | 181.18%805.92K | -45.02%544.06K | -63.28%278.3K | 63.81%552.6K | -82.89%286.62K | -20.34%989.57K | -97.43%757.81K | -98.75%337.35K | -93.30%1.67M | -96.24%1.24M |
Goodwill | -42.43%96.63M | -42.43%96.63M | -68.77%167.85M | -68.77%167.85M | -68.77%167.85M | -68.77%167.85M | -38.35%537.39M | -38.35%537.39M | -38.35%537.39M | -38.35%537.39M |
Long deferred expense | -8.15%680.51M | -16.97%646M | -19.43%672.72M | -22.35%714.96M | -31.44%740.91M | -34.11%777.99M | -42.26%835.01M | -37.62%920.78M | -30.52%1.08B | -20.61%1.18B |
Deferred tax assets | -29.00%13.94M | -54.55%12.22M | -75.80%16.26M | -38.91%30.98M | -76.71%19.64M | -71.53%26.89M | -66.33%67.21M | -72.74%50.72M | -48.45%84.3M | -51.75%94.43M |
Usufruct assets | -50.43%491.85M | -56.32%450.14M | -53.16%587.47M | -43.48%834.78M | -49.49%992.31M | -57.35%1.03B | -62.52%1.25B | -57.56%1.48B | -46.84%1.96B | -37.38%2.42B |
Other non current assets | 2.60%320.67M | 6.35%330.23M | 0.91%318.27M | -3.38%303.01M | -0.71%312.55M | -19.25%310.52M | -17.72%315.41M | -9.54%313.6M | -59.95%314.8M | 9.95%384.54M |
Total non current assets | -7.89%20.2B | -8.66%20.16B | -8.01%21.28B | -8.02%21.69B | -10.64%21.94B | -12.78%22.07B | -15.30%23.13B | -14.32%23.58B | -11.01%24.55B | -7.48%25.3B |
Total assets | -7.56%22.1B | -8.34%22.13B | -4.60%23.51B | -6.59%23.47B | -10.96%23.91B | -13.51%24.14B | -18.65%24.65B | -18.70%25.12B | -15.66%26.85B | -13.69%27.91B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | ---- | ---- | -95.29%286.66M | -2.30%6.1B | -2.45%6.1B | -6.01%6.11B | -6.78%6.09B | -12.80%6.25B | -16.20%6.25B | -17.54%6.51B |
Notes payable and accounts payable | -75.57%596.95M | -69.68%772.5M | -63.45%896.92M | -6.70%2.43B | -20.32%2.44B | -31.72%2.55B | -21.14%2.45B | -26.54%2.61B | -27.25%3.07B | -11.71%3.73B |
-Notes payable | --0 | --0 | --0 | ---- | -99.25%4.08M | -99.03%5.5M | -99.22%6.39M | -82.75%103.75M | -26.49%542.19M | -13.97%565.51M |
-Accounts payable | -75.53%596.95M | -69.61%772.5M | -63.36%896.92M | -2.84%2.43B | -3.36%2.44B | -19.70%2.54B | 6.53%2.45B | -15.07%2.5B | -27.42%2.52B | -11.30%3.17B |
Contract liabilities | 7.37%635.81M | 5.94%607.54M | 8.57%654.9M | -11.78%612.37M | -25.28%592.17M | -38.57%573.48M | -53.94%603.2M | -55.18%694.1M | -57.28%792.49M | -48.66%933.62M |
Salaries payable | -67.99%84.38M | -67.35%84.61M | -81.12%65.17M | -26.38%256.64M | -24.14%263.62M | -29.90%259.14M | 26.10%345.21M | 127.64%348.61M | 194.02%347.51M | 258.22%369.7M |
Taxs payable | -74.51%55.58M | -77.32%51.5M | -73.01%62.91M | -11.32%179.24M | 36.38%218.03M | 84.88%227.09M | 77.38%233.03M | 90.80%202.13M | 113.35%159.87M | 57.44%122.83M |
Other payable (including interest and dividends) | -52.02%2.14B | -50.05%2.27B | -33.48%2.28B | 44.33%4.38B | 15.81%4.47B | 20.21%4.55B | -8.62%3.42B | -16.02%3.03B | 18.74%3.86B | 17.73%3.79B |
-Dividend payable | 0.00%21.14M | 0.00%21.14M | 0.00%21.14M | 0.00%21.14M | 0.00%21.14M | 0.00%21.14M | -39.12%21.14M | -74.46%21.14M | --21.14M | --21.14M |
-Other payable | ---- | ---- | ---- | 44.64%4.36B | ---- | 20.32%4.53B | ---- | -14.65%3.01B | ---- | 17.07%3.77B |
Non current liabilities due within one year | -56.33%176.21M | -51.63%183.2M | -72.90%186.7M | 15.67%812.8M | -36.88%403.51M | -44.82%378.78M | -6.99%688.83M | -7.38%702.7M | 93.15%639.29M | -13.99%686.49M |
Other current liabilities | 8.16%82.48M | 6.82%78.93M | 8.46%84.36M | -12.02%78.86M | -25.72%76.26M | -36.48%73.89M | -54.19%77.78M | -55.49%89.64M | -57.35%102.66M | -41.02%116.32M |
Total current liabilities | -74.08%3.77B | -72.48%4.05B | -67.56%4.51B | 6.68%14.86B | -4.30%14.56B | -9.39%14.73B | -13.12%13.91B | -18.54%13.93B | -13.26%15.22B | -11.32%16.25B |
Current liabilities | ||||||||||
Long term loan | 69.76%6.35B | 67.20%6.31B | 125.15%7.95B | -7.63%3.3B | -1.24%3.74B | 20.45%3.77B | 53.94%3.53B | 110.34%3.57B | 141.31%3.79B | 99.45%3.13B |
Long term account payable | ---- | ---- | ---- | 0.00%600M | ---- | ---- | ---- | --600M | ---- | --0 |
Specific account payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -85.16%520K |
Estimate liabilities | 11.02%8.27M | 11.02%8.27M | -77.21%8.93M | -78.03%7.57M | -59.86%7.45M | -59.86%7.45M | --39.17M | --34.48M | --18.56M | --18.56M |
Deferred tax liabilities | 15.23%803.68M | 13.30%795.66M | -8.08%719.19M | -16.14%687.87M | -8.66%697.43M | -15.42%702.27M | 14.23%782.45M | 16.98%820.25M | 7.97%763.54M | 11.48%830.35M |
Long term deferred income | -21.33%7.93M | -24.94%8.23M | -30.80%8.69M | -33.96%9.2M | -21.56%10.08M | -36.51%10.97M | -17.67%12.55M | -14.16%13.93M | -26.25%12.85M | -1.87%17.27M |
Lease liabilities | -50.61%530.32M | -55.49%501.01M | -50.25%673.39M | -41.22%903.46M | -47.91%1.07B | -54.38%1.13B | -62.53%1.35B | -58.81%1.54B | -52.53%2.06B | -39.23%2.47B |
Total non current liabilities | 62.33%9.95B | 58.49%9.86B | 59.51%10.08B | -16.27%5.51B | -7.75%6.13B | -3.82%6.22B | -4.35%6.32B | 7.00%6.58B | 0.07%6.65B | 1.10%6.47B |
Total liabilities | -33.67%13.72B | -33.59%13.91B | -27.86%14.59B | -0.68%20.36B | -5.35%20.69B | -7.81%20.95B | -10.56%20.23B | -11.78%20.5B | -9.60%21.86B | -8.11%22.72B |
Shareholders equity | ||||||||||
Paid-in capital | 220.00%2.69B | 211.23%2.69B | 211.23%2.69B | -2.74%840.22M | -2.74%840.22M | 0.00%863.9M | 0.00%863.9M | 0.00%863.9M | 0.00%863.9M | 0.00%863.9M |
Capital reserve funds | 60.41%5.35B | 47.19%5.31B | 44.54%5.22B | -7.65%3.33B | -7.62%3.33B | 0.03%3.61B | 0.00%3.61B | -0.20%3.61B | -0.24%3.61B | -0.24%3.61B |
Surplus reserve funds | 0.00%313.79M | 0.00%313.79M | 0.00%313.79M | 0.00%313.79M | 0.00%313.79M | 0.00%313.79M | -0.13%313.79M | -0.13%313.79M | -0.13%313.79M | -0.13%313.79M |
Retained profit | 30.37%-3B | 27.95%-3.12B | 25.48%-2.32B | -51.88%-4.41B | -68.82%-4.32B | -77.17%-4.34B | -2,935.42%-3.11B | -2,660.84%-2.91B | -1,362.29%-2.56B | -1,502.74%-2.45B |
Less:Treasury stock | 0.00%700.16 | -100.00%700.16 | -100.00%700.16 | -100.00%700.16 | -100.00%700.16 | 0.00%299.93M | 0.00%299.93M | -9.75%299.93M | -25.02%299.93M | -25.02%299.93M |
Other composite income | -1.07%2.68B | -1.21%2.68B | -1.07%2.67B | -0.54%2.69B | -0.24%2.71B | -2.93%2.71B | -0.41%2.7B | -0.39%2.7B | 0.66%2.71B | 3.67%2.79B |
Shareholders equity without minority interests | 178.69%8.02B | 174.95%7.87B | 110.22%8.57B | -35.52%2.76B | -38.00%2.88B | -40.76%2.86B | -44.19%4.08B | -41.22%4.29B | -36.33%4.64B | -33.48%4.83B |
Minority interests | 4.55%354.53M | 4.33%349M | 1.74%343.5M | 2.16%341.4M | -2.61%339.11M | -8.04%334.51M | -9.04%337.62M | -9.11%334.19M | -4.06%348.2M | 2.10%363.76M |
Total shareholder equity | 160.34%8.38B | 157.10%8.22B | 101.93%8.92B | -32.80%3.1B | -35.53%3.22B | -38.47%3.2B | -42.49%4.42B | -39.68%4.62B | -34.80%4.99B | -31.82%5.2B |
Total liabilityies and equity | -7.56%22.1B | -8.34%22.13B | -4.60%23.51B | -6.59%23.47B | -10.96%23.91B | -13.51%24.14B | -18.65%24.65B | -18.70%25.12B | -15.66%26.85B | -13.69%27.91B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.